Benedetta Riboldi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pain in Fabry disease: do experimental models reveal novel therapeutic targets?

Pain in Fabry disease: do experimental models reveal novel therapeutic targets?

Journal: Biochemical pharmacology

Published: April 30, 2026

Cell-Free Therapies for Chronic Pain: The Rise of the Mesenchymal Stem Cell Secretome.

Cell-Free Therapies for Chronic Pain: The Rise of the Mesenchymal Stem Cell Secretome.

Journal: Brain sciences

Published: October 20, 2025

The prokineticin system and glia cells as pharmacological targets to control neuroinflammation and to relieve pain in a murine model of Fabry-Anderson disease.

The prokineticin system and glia cells as pharmacological targets to control neuroinflammation and to relieve pain in a murine model of Fabry-Anderson disease.

Journal: Pain

Published: June 26, 2025

Physical exercise ameliorates pain, mood alterations and neuroinflammation in a murine model of osteoarthritis.

Physical exercise ameliorates pain, mood alterations and neuroinflammation in a murine model of osteoarthritis.

Journal: Life sciences

Published: January 07, 2025

Prevention of motor relapses and associated trigeminal pain in experimental autoimmune encephalomyelitis by reducing neuroinflammation with a purple corn extract enriched in anthocyanins.

Prevention of motor relapses and associated trigeminal pain in experimental autoimmune encephalomyelitis by reducing neuroinflammation with a purple corn extract enriched in anthocyanins.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 06, 2024

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies.

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies.

Journal: Cells

Published: March 11, 2024

Neuroinflammation in osteoarthritis: From pain to mood disorders.

Neuroinflammation in osteoarthritis: From pain to mood disorders.

Journal: Biochemical pharmacology

Published: February 06, 2024

The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview.

The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview.

Journal: Biomedicines

Published: September 26, 2023

Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model.

Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model.

Journal: Cells

Published: July 12, 2023

Modulation of Glial Cell Functions by the Gut-Brain Axis: A Role in Neurodegenerative Disorders and Pain Transmission.

Modulation of Glial Cell Functions by the Gut-Brain Axis: A Role in Neurodegenerative Disorders and Pain Transmission.

Journal: Cells

Published: April 28, 2023

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine.

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine.

Journal: International journal of molecular sciences

Published: October 13, 2022

Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration.

Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration.

Journal: Biochemical pharmacology

Published: July 08, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026